Sanofi News - SAN

Stock Name Stock Symbol Market Stock Type
Sanofi SAN Euronext Ordinary Share
  Price Change Price Change % Stock Price Last Trade
0.54 0.62% 87.54 03:40:00
Open Price Low Price High Price Close Price Previous Close
86.77 86.75 87.60 87.54 87.00
more quote information »

Recent News

Date Time Source Heading
18/11/202205:29DJNSanofi Gets EU Nod on Hemolytic Anemia Drug
18/11/202204:50GLOBEPress Release: European Commission approves Enjaymo®..
15/11/202209:42GLOBESanofi: Informations relatives au nombre de droits de vote..
11/11/202223:56DJNRegeneron, Sanofi Get CHMP Backing for Dupixent in Prurigo..
11/11/202223:00GLOBEPress Release: Dupixent® (dupilumab) recommended for EU..
11/11/202202:36GLOBECommuniqué de presse : VidPrevtyn® Beta, le vaccin de rappel..
04/11/202218:52DJNAstraZeneca's Nirsevimab Approved in the EU
04/11/202218:00GLOBEPress Release: European Commission grants first approval..
28/10/202217:01DJNSanofi 3Q Sales Climb; Raises 2022 Business EPS Guidance
28/10/202216:30GLOBECommuniqué de Presse : Forte performance au T3 et avancées..
14/10/202206:58GLOBESanofi: Informations relatives au nombre de droits de vote..
11/10/202216:00GLOBECommuniqué de presse: Des données de phase III de dernière..
07/10/202202:03DJNProvention Bio Shares Rise 21% After Co-Promotion Agreement..
06/10/202223:10DJNProvention Bio, Sanofi Set Co-Promotion Pact for Teplizumab..
01/10/202205:11DJNCorrection to Sanofi and Regeneron Pharmaceuticals Article..
29/9/202209:05DJNSanofi, Regeneron Say Dupixent Gets FDA Approval to Treat..
29/9/202208:05GLOBEPress Release: Dupixent® (dupilumab) approved by FDA as the..
28/9/202215:30GLOBECommuniqué de presse : Mise en ligne du document «Q3 2022..
16/9/202216:45DJNAstraZeneca Says Nirsevimab Recommended for Approval in EU
16/9/202216:00GLOBECommuniqué de presse: Le CHMP recommande l’approbation de..
14/9/202205:24GLOBESanofi: Information concerning the total number of voting..
09/9/202201:30GLOBECommuniqué de presse: Des données de phase III de dernière..
01/9/202204:30GLOBEPress Release: XenpozymeTM (olipudase alfa-rpcp) approved by..
30/8/202216:28DJNSanofi Hemophilia Drug Granted Priority Review by U.S. FDA
30/8/202215:30GLOBEPress Release: FDA grants priority review to efanesoctocog..
17/8/202222:02DJNTrending: Sanofi Stops Development of Breast-Cancer Drug..
17/8/202218:15DJNSanofi Shares Drop After End of Development Program for..
17/8/202216:39DJNSanofi Stops Development Program for Breast-Cancer Treatment..
17/8/202215:30GLOBECommuniqué de presse: Sanofi fait le point sur le programme..
12/8/202218:48DJNGSK, Sanofi, Haleon Shares Recover Some Recent Losses After..
12/8/202217:30DJNHaleon Says It Hasn't Been Notified About Litigation on..
11/8/202205:29DJNSanofi Down Nearly 8%, On Track for Largest Percent Decrease..
09/8/202205:03GLOBESanofi: Informations relatives au nombre de droits de vote..
05/8/202202:36DJNSanofi, Innovent Biologics to Collaborate on Oncology..
05/8/202201:30GLOBECommuniqué de presse : Sanofi et Innovent Biologics nouent..
28/7/202222:29GLOBECommuniqué de presse : Mise en ligne du rapport financier..
28/7/202216:05DJNSanofi Upgrades Fiscal Year Guidance as 2Q Sales Rose 16%
28/7/202215:30GLOBEPress Release: Strong execution in Q2 drives full-year 2022..
21/7/202202:52GLOBESanofi: Information concerning the total number of voting..
14/7/202215:00GLOBECommuniqué de presse: Résultats positifs de phase III pour..
10/7/202223:45GLOBEDes données pivots démontrent que l’efanesoctogog alpha une..
04/7/202220:00GLOBESanofi Global Health launches nonprofit Impact® brand for 30..
01/7/202201:42DJNSanofi on Pace for Largest Percent Decrease Since April 2020..
30/6/202220:29DJNSanofi's Phase 3 Trials of Multiple Sclerosis Drug Partially..
28/6/202215:30GLOBECommuniqué de presse: Xenpozyme® (olipudase alpha) approuvé..
28/6/202206:57GLOBESanofi: Information concerning the total number of voting..
25/6/202204:05DJNSanofi On Pace for Largest Percent Increase Since November..
24/6/202216:21DJNSanofi, GSK Report Successful Vaccine Study Against Omicron
24/6/202215:32GLOBEMise en ligne du document «Q2 2022 Memorandum for modelling..
24/6/202215:28GLOBEPress Release: Sanofi-GSK first to report a successful..
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221127 05:44:46